Amgen stock heads into the open after a 1.55% pullback
Published on 09/07/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 4, 2026, Amgen stock settled at USD 437.23 on the Nasdaq, marking a 1.55% decline from the prior session as shown by Investing.com price data. The move left the share price within a session range between USD 435.00 and USD 441.85 and followed several days of trading not far below the recent 52-week high.
September 4, 2026 in numbers
Amgen Inc. (ISIN US0311621009, Nasdaq: AMGN) closed at USD 437.23 on the Nasdaq on September 4, 2026, down from USD 444.12 in the previous session, according to the Nasdaq-listed historical data at Investing.com Amgen historical prices. During that session the shares traded between a low of USD 435.00 and a high of USD 441.85, with reported volume of about 1.66 million shares. The latest close left Amgen less than USD 10 below its documented 52-week high of USD 447.03 and well above the 52-week low of USD 269.77, underlining the strong medium-term price recovery.
While Amgen eased by 1.55% on September 4, 2026, the broader S&P 500 index also slipped modestly, signaling a softer tone across US equities rather than a stock-specific shock. In the context of the preceding week, Amgen remained up compared with the August 31, 2026 close at USD 429.88, meaning the stock still carried a gain of roughly USD 7 over that five-session span despite the latest pullback.
Today’s outlook for Amgen
Today, September 7, 2026, US exchanges are closed for the Labor Day holiday, so Amgen will not trade on its primary Nasdaq venue and the next session is due on September 8, 2026. Company-specific events for Amgen around this date are centered on its regular investor communications calendar, while market participants will also look ahead to upcoming US economic releases and central-bank commentary later in the week that can shape sentiment toward large pharmaceutical and biotechnology names such as Amgen.
